HAIFA, Israel--(BUSINESS WIRE)--Bonus BioGroup announces that first transplantation of its proprietary live bone grafts in human was performed successfully. The clinical trial is designed to treat deficient facial bone tissues, including upper and lower jawbone cavitations, by transplantation of live bone implants comprising of cells originating from patients’ own fat tissue and manufactured in Bonus BioGroup’s Manufacturing Facility.
Help employers find you! Check out all the jobs and post your resume.
